Pictured: MTPConnect Managing Director & CEO Dr Dan Grant, GM Stakeholder Engagement Dr Alfredo Martinez-Coll and Director Stakeholder Engagement Dr Kate Brooks with the 2019 MTPConnect-led Australian delegation to The MedTech Conference in Boston.
The 2019 MedTech Conference
We’re fresh back from Boston where the MTPConnect team has wrapped-up a busy, exciting and rewarding week at the 2019 MedTech Conference. A big thank you to the 30 delegates representing 27 companies, research institutes, universities and start-ups who traveled with us to Massachusetts to fly the flag for Australian medtech innovation on the world stage. And a big shout out to Dr Kath Giles and her team at OncoRes Medical who placed in the top five in the finals of the MedTech Innovator competition; winning US$25,000 and lots of admiration from all the conference delegates. MTPConnect was proud to work with Austrade, MTAA and AusBiotech on this mission and we’re grateful for the support of the Victorian, Western Australian and Queensland state governments as well as the Entrepreneurs’ Programme’s Accelerating Commercialisation initiative. As everyone in the delegation knows, our team of Dr Alfredo Martinez-Coll, Dr Kate Brooks and Libby Pearce did a fantastic job in coordinating the visit and putting together the program of extra meetings and activities that add such value to these missions.
Introducing Noisy Guts – an Australian Nobel Laureate’s take on MedTech Commercialisation
The MTPConnect podcast introduced listeners to the Noisy Guts story, a WA-based start-up developing new diagnostics for gut health that has worked with Professor Barry Marshall, Director of the University of Western Australia’s Marshall Centre for Infectious Diseases, Research and Training and winner of the 2005 Nobel Prize for his work on the causes of ulcers. Noisy Guts CEO & Co-Founder Dr Josephine Muir and Professor Marshall explored the challenges of translation and shared valuable lessons from building their own start-up. More of the chat with Professor Marshall and Dr Muir can be heard in our podcast - it’s available to download wherever you get your podcasts.
2019 MTAA MedTech Conference
MTPConnect was proud to sponsor MTAA’s MedTech 19 Conference, where our team of Elizabeth Stares and Andrew Bowskill were on the ground to hear insights from speakers about the issues and challenges affecting Australian and international medtech. A conference highlight was the MedTech Actuator facilitating a MedTech’s Got Talent Sydney Rapid Fire Round where 15 entrepreneurs pitched to secure places in the finals, to be held in December in Melbourne.
ARMS 2019 Conference
MTPConnect Chair Sue MacLeman spoke at ARMS 2019 Conference in Adelaide presenting a keynote on emerging megatrends in health and medical research in Australia and the threats and opportunities they present.
Australia New Zealand Leadership Forum
Earlier this month, MTPConnect were the emerging leaders sponsors of the ANZLF Forum in Auckland. Nick Cerneaz, one of MTPConnect’s Board Directors, joined forum members and emerging business leaders Chandra Selvadurai, William Stubbs Smith, Mary-Ellen Redmayne, Jordan Go, Pete Williams & Gavin Fox-Smith, to talk about ways to further strengthen the Trans-Tasman bonds between Australia and New Zealand’s research efforts.
2019 BridgeTech Program Close Event
Our newly appointed Director of Stakeholder Engagement QLD, Andrew Bowskill, attended the close of the BridgeTech Program’s second cohort in Brisbane. The event shared the first cohort’s achievements, which included five participants who had initiated or completed on R&D contracts, eight participants who had pitched to investors or industry representatives, four participants were involved in developing new start-ups and more.
The MTPConnect podcast series goes from strength to strength and September has been another big month. Make sure you download our pre-MedTech Conference chat with Hydrix, our on-the-ground coverage of the event directly from the Boston Convention and Exhibition Centre - and don’t forget to check out what Australian Nobel Laureate Professor Barry Marshall has to stay about the challenges of research translation and commercialisation.